4.7 Article

Abnormal N400 word repetition effects in fragile X-associated tremor/ataxia syndrome

Journal

BRAIN
Volume 133, Issue -, Pages 1438-1450

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/brain/awq077

Keywords

electroencephalogram; event-related potential; late positive component; P600; memory; language processing; aging

Funding

  1. National Institutes of Health [UL1DE019583 (NIDCR), RL1AG032115 (NIA), RL1AG032119 (NIA)]
  2. National Institute on Aging (NIA) [AG18442]

Ask authors/readers for more resources

Fragile X-associated tremor/ataxia syndrome, a neurodegenerative disorder associated with premutation alleles (55-200 CGG repeats) of the FMR1 gene, affects many carriers in late-life. Patients with fragile X-associated tremor/ataxia syndrome typically have cerebellar ataxia, intranuclear inclusions in neurons and astrocytes, as well as cognitive impairment. Dementia can also be present with cognitive deficits that are as severe as in Alzheimer's disease, however frontosubcortical type impairment is more pronounced in fragile X-associated tremor/ataxia syndrome. We sought to characterize the P600 and N400 word repetition effects in patients with fragile X-associated tremor/ataxia syndrome, using an event-related potential word repetition paradigm with demonstrated sensitivity to very early Alzheimer's disease. We hypothesized that the fragile X-associated tremor/ataxia syndrome-affected participants with poor declarative verbal memory would have pronounced abnormalities in the P600 repetition effect. In the event-related potential experiment, subjects performed a category decision task whilst an electroencephalogram was recorded. Auditory category statements were each followed by an associated visual target word (50% 'congruous' category exemplars, 50% 'incongruous' nouns). Two-thirds of the stimuli (category statement-target word pairs) were repeated, either at short-lag (similar to 10-40 s) or long-lag (similar to 100-140 s). The N400 and P600 amplitude data were submitted to split-plot analyses of variance. These analyses of variance showed a highly significant reduction of the N400 repetition effect (F = 22.5, P < 0.001), but not of the P600 repetition effect, in mild fragile X-associated tremor/ataxia syndrome (n = 32, mean age = 68.7, mean Mini-Mental State Examination score = 26.8). Patients with fragile X-associated tremor/ataxia syndrome had significantly smaller late positive amplitude (550-800 ms post-stimulus onset) to congruous words (P = 0.04 for group effect). Reduced P600 repetition effect amplitude was associated with poorer recall within fragile X-associated tremor/ataxia syndrome patients (r = 0.66) and across all subjects (r = 0.52). Larger P600 amplitude to new congruous words also correlated significantly with higher free recall scores (r = 0.37, P < 0.01) across all subjects. We found a correlation between the amplitude of late positivity and CGG repeat length in those with fragile X-associated tremor/ataxia syndrome (r = 0.47, P = 0.006). Higher levels of FMR1 mRNA were associated with smaller N400s to incongruous words and larger positive amplitudes (between 300 and 500 ms) to congruous words. In conclusion, event-related potential word repetition effects appear sensitive to the cognitive dysfunction present in patients with mild fragile X-associated tremor/ataxia syndrome. Their more severe reduction in N400 repetition effect, than P600, is in contrast to the reverse pattern reported in amnestic mild cognitive impairment and incipient Alzheimer's disease (Olichney et al., 2008).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Psychiatry

Elevated FMR1-mRNA and lowered FMRP - A double-hit mechanism for psychiatric features in men with FMR1 premutations

Andrea Schneider, Tri Indah Winarni, Ana Maria Cabal-Herrera, Susan Bacalman, Louise Gane, Paul Hagerman, Flora Tassone, Randi Hagerman

TRANSLATIONAL PSYCHIATRY (2020)

Article Biochemistry & Molecular Biology

Characterization of the Metabolic, Clinical and Neuropsychological Phenotype of Female Carriers of the Premutation in the X-Linked FMR1 Gene

Eleonora Napoli, Yingratana Amabel McLennan, Andrea Schneider, Flora Tassone, Randi J. Hagerman, Cecilia Giulivi

FRONTIERS IN MOLECULAR BIOSCIENCES (2020)

Article Behavioral Sciences

Fear Potentiated Startle in Children With Autism Spectrum Disorder: Association With Anxiety Symptoms and Amygdala Volume

David Hessl, Lauren Libero, Andrea Schneider, Connor Kerns, Breanna Winder-Patel, Brianna Heath, Joshua Lee, Cory Coleman, Natasha Sharma, Marjorie Solomon, Christine Wu Nordahl, David G. Amaral

Summary: The study found that the connection between fear conditioning and anxiety in children with autism spectrum disorder (ASD) depends on the size of the amygdala.

AUTISM RESEARCH (2021)

Review Biotechnology & Applied Microbiology

Next-generation strategies for gene-targeted therapies of central nervous system disorders: A workshop summary

Jill A. Morris, Chris H. Boshoff, Nina F. Schor, Ling M. Wong, Guangping Gao, Beverly L. Davidson

Summary: NINDS organized a workshop on gene-targeted therapies for CNS disorders, bringing together experts from various fields to identify challenges and propose solutions. Prior to the workshop, key obstacles and research gaps were identified through pre-meeting teleconferences, allowing for problem-solving discussions and strategy development at the workshop.

MOLECULAR THERAPY (2021)

Article Neurosciences

Case Report: Coexistence of Alzheimer-Type Neuropathology in Fragile X-Associated Tremor Ataxia Syndrome

Maria Jimena Salcedo-Arellano, Desiree Sanchez, Jun Yi Wang, Yingratana A. McLennan, Courtney Jessica Clark, Pablo Juarez, Andrea Schneider, Flora Tassone, Randi J. Hagerman, Veronica Martinez-Cerdeno

Summary: This case report documents the co-occurrence of FXTAS and AD in a 71-year-old carrier with rapid cognitive decline and remarkable MRI changes.

FRONTIERS IN NEUROSCIENCE (2021)

Letter Biotechnology & Applied Microbiology

NINDS launches network to develop treatments for ultra-rare neurological diseases

Nina F. Schor, Amir P. Tamiz, Walter J. Koroshetz, Ann-Marie Broome, Julia L. Bachman, Chris Boshoff, Janice Cordell, Neel T. Dhruv, Amelie Gubitz, Adam L. Hartman, Walter J. Koroshetz, Genevieve E. Lind, Codrin I. Lungu, Jill A. Morris, Glen H. Nuckolls, Shantadurga Rajaram, Ranga Rangarajan, Rebecca A. Roof, Nina F. Schor, Mario H. Skiadopoulos, Natalia Strunnikova, Amir P. Tamiz, Ling M. Wong, Clinton B. Wright

NATURE BIOTECHNOLOGY (2021)

Article Psychiatry

EEG Signal Complexity Is Reduced During Resting-State in Fragile X Syndrome

Melodie Proteau-Lemieux, Inga Sophia Knoth, Kristian Agbogba, Valerie Cote, Hazel Maridith Barlahan Biag, Angela John Thurman, Charles-Olivier Martin, Anne-Marie Belanger, Cory Rosenfelt, Flora Tassone, Leonard J. Abbeduto, Sebastien Jacquemont, Randi Hagerman, Francois Bolduc, David Hessl, Andrea Schneider, Sarah Lippe

Summary: Research compared brain signal features between FXS patients and neurotypical controls, revealing significant changes in signal complexity in FXS patients, indicating potential brain alterations.

FRONTIERS IN PSYCHIATRY (2021)

Article Psychiatry

Increased Pain Symptomatology Among Females vs. Males With Fragile X-Associated Tremor/Ataxia Syndrome

Devon Johnson, Ellery Santos, Kyoungmi Kim, Matthew D. Ponzini, Yingratana A. McLennan, Andrea Schneider, Flora Tassone, Randi J. Hagerman

Summary: Individuals with the fragile X premutation often experience chronic pain symptoms, with women being more likely than men to experience pain, particularly allodynia, peripheral neuropathy pain, migraine, fibromyalgia, and back pain. Onset of peripheral neuropathy predicts the onset of ataxia and tremor, and women also report higher levels of anxiety.

FRONTIERS IN PSYCHIATRY (2022)

Article Clinical Neurology

Neuropsychological changes in FMR1 premutation carriers and onset of fragile X-associated tremor/ataxia syndrome

Jessica Famula, Emilio Ferrer, Randi J. Hagerman, Flora Tassone, Andrea Schneider, Susan M. Rivera, David Hessl

Summary: Carriers of the FMR1 premutation have an increased risk of developing FXTAS, a neurodegenerative disease characterized by intention tremor, ataxia, and cognitive decline. Longitudinal study showed that FMR1 premutation carriers exhibited greater rates of decline in visual working memory, motor dexterity, inhibitory control, and manual movement speed. The findings suggest that executive function decline and subtle motor changes may precede and track with the emergence of FXTAS symptoms.

JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2022)

Correction Psychiatry

EEG Signal Complexity Is Reduced During Resting-State in Fragile X Syndrome (vol 12, 716707, 2021)

Melodie Proteau-Lemieux, Inga Sophia Knoth, Kristian Agbogba, Valerie Cote, Hazel Maridith Barlahan Biag, Angela John Thurman, Charles-Olivier Martin, Anne-Marie Belanger, Cory Rosenfelt, Flora Tassone, Leonard J. Abbeduto, Sebastien Jacquemont, Randi Hagerman, Francois Bolduc, David Hessl, Andrea Schneider, Sarah Lippe

FRONTIERS IN PSYCHIATRY (2022)

Article Genetics & Heredity

Fragile X-Associated Neuropsychiatric Disorders (FXAND) in Young Fragile X Premutation Carriers

Ramkumar Aishworiya, Dragana Protic, Si Jie Tang, Andrea Schneider, Flora Tassone, Randi Hagerman

Summary: This study identified a high prevalence of fragile X-associated neurodevelopmental disorders (FXAND) in a sample of young individuals with fragile X premutation carrier state (PM). The presence of FXAND and early recognition of associated symptoms may facilitate timely and appropriate care for PM individuals.

GENES (2022)

Article Medicine, General & Internal

Tophaceous gout of the nose in a male FMR1 premutation carrier

Si Jie Tang, Shanthi Giri, Nima Pahlavan, Sophia H. Han, Ellery R. Santos, Glenda Espinal, Ramkumar Aishworiya, Andrea Schneider, David Hessl, Susan M. Rivera, Randi J. Hagerman

Summary: In this case study, we report a 68-year-old male with FXTAS who presented with uncontrolled gout involving multiple sites, including a rare gouty tophus in the nasal region.

CLINICAL CASE REPORTS (2022)

Article Cell Biology

Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X Syndrome

Ramkumar Aishworiya, Mei-Hung Chi, Marwa Zafarullah, Guadalupe Mendoza, Matthew Dominic Ponzini, Kyoungmi Kim, Hazel Maridith Barlahan Biag, Angela John Thurman, Leonard Abbeduto, David Hessl, Jamie Leah Randol, Francois V. Bolduc, Sebastien Jacquemont, Sarah Lippe, Paul Hagerman, Randi Hagerman, Andrea Schneider, Flora Tassone

Summary: This study provides insights into the use of molecular biomarkers to identify clinical phenotypes of fragile X syndrome (FXS). Findings show positive correlations between FMR1 mRNA expression levels and adaptive functioning, language, and specific NIH Toolbox measures. Other correlations include MMP-9 levels with obesity, CYFIP1 mRNA with mood and autistic symptoms, and FMR1 mRNA expression level with better cognitive, language, and adaptive functions. These potential biomarkers could guide future targeted treatments for FXS.

CELLS (2023)

Meeting Abstract Education, Special

CLINICAL PHENOTYPE AND MOLECULAR BIOMARKERS IN FRAGILE X SYNDROME

R. Aishworiya, M. Zafarullah, M. J. Salcedo-Arellano, K. Kim, H. Biag, A. Schneider, D. Hessl, F. Tassone, R. Hagerman

JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2022)

Review Clinical Neurology

Review of Autism Profiles and Response to Sertraline in Fragile X Syndrome-Associated Autism vs. Non-syndromic Autism; Next Steps for Targeted Treatment

Akash Rajaratnam, Laura Axelrod Potter, Hazel Maridith Barlahan Biag, Andrea Schneider, Ignacio Cortina Petrasic, Randi Jenssen Hagerman

FRONTIERS IN NEUROLOGY (2020)

No Data Available